In addition, serum YKL-40 levels are higher in patients with active sarcoidosis than those with inactive sarcoidosis and directly correlate with both sIL-2R and sACE levels in patients with active sarcoidosis, suggesting that YKL-40 is a marker for granuloma burden [111]. The gene discussed is CHI3L1; the disease is sarcoidosis.